Christopher A. Alfonzo

Christopher Alfonzo practices at Great Plains Health in North Platte, Nebraska, part of Great Plains Health.

Christopher Alfonzo's NPI, 1437120433, was assigned on January 28, 2006. Christopher Alfonzo graduated from Uniformed Services University, F. Edward Hebert School of Medicine in 2000. Christopher Alfonzo holds California license C146907.

Christopher Alfonzo's primary practice is Great Plains Health, at 601 West Leota St, North Platte, NE 69101 in Lincoln County. The practice phone is (308) 568-8000.

Christopher Alfonzo's primary practice is Great Plains Health in North Platte, Nebraska, part of Great Plains Health. Christopher Alfonzo is also affiliated with Ogallala Community Hospital. The medical group on file is Great Plains Health. Dmand AI also links Christopher Alfonzo to 1 more group practice or clinic and 1 medical group, each named with a free account. Christopher Alfonzo's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher Alfonzo practices, 3 sites in all. Vendor and product names are available with a free account.

Psychiatry is Christopher Alfonzo's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Christopher Alfonzo is board certified in addiction medicine by the American Board of Preventive Medicine. Dmand AI has Christopher Alfonzo's licenses on file in 6 states: California, Nebraska, Florida, Idaho, Alabama and Virginia.

Dmand AI lists adjustment disease, alcohol use disorders, anxiety, bipolar disorder, depression, insomnia, intellectual and developmental disabilities and non-alzheimer's dementia (chronic) among the conditions Christopher Alfonzo treats.

CMS data shows 260 Medicare services from Christopher Alfonzo across 3 procedure codes in 2024, for 73 Medicare patients. Medicare paid $17,986 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 73 Medicare patients who saw Christopher Alfonzo in 2024. The largest group is under 65, with 41 patients. 75% of them have anxiety, and 75% have mood disorders. 52% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Christopher Alfonzo's median patient age at 59, with 56% women.

In 2024, Christopher Alfonzo wrote 1,294 Medicare Part D claims for 79 patients. 96% of them were for generic drugs. CMS names the drug for 1,112 of them, across 35 drugs with 11 or more claims each, at $79,081 in total drug cost. In 2023, CMS named 619 claims across 24 drugs.

Christopher Alfonzo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Christopher Alfonzo as offering telehealth.

Dmand AI links 1 paper to Christopher Alfonzo. Christopher Alfonzo's most frequent co-authors are Myron D. Almond, MD and William Victor Bobo, MD.

CMS Open Payments shows 131 general payments to Christopher Alfonzo from 12 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,126.

Christopher Alfonzo graduated from Uniformed Services University, F. Edward Hebert School of Medicine in 2000.

Christopher Alfonzo is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.